Lucintel Forecasts the Global Anti-Biofilm Wound Dressing Market to Reach $1.4 billion by 2030
Lucintel Forecasts the Global Anti-Biofilm Wound Dressing Market to Reach $1.4 billion by 2030
Blog Article
According to a market report by Lucintel, the future of the global anti-biofilm wound dressing market looks promising with opportunities in the hospitals and clinics and surgical centers markets. The global anti-biofilm wound dressing market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising prevalence of persistent conditions like diabetes, cancer, and autoimmune disorders and growing demand for wound care products along with surging number of surgical procedures around the globe.
A more than 150 – page report is developed to understand Trends, opportunity and forecast in anti-biofilm wound dressing market to 2030 by mode of mechanism (physical, chemical, and biological), application (chronic wounds and acute wounds), end use (hospitals and clinics, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, physical, chemical, and biological are the major segments of anti-biofilm wound dressing market by mode of mechanism. Lucintel forecasts that chemical will remain the largest segment over the forecast period due to increasing prevalence of chronic wounds and rising number of surgeries.
Within this market, hospitals will remain the larger segment due to rising sports-related injuries, burn and trauma cases.
Download sample by clicking on anti-biofilm wound dressing market
North America will remain the largest region over the forecast period due to growing incidence of sports injuries and presence of key players in the region.
Convatec, Smith & Nephew, Urgo Medical, Coloplast, 3M, Mölnlycke Health Care, Imbed Biosciences, Next Science, B. Braun Melsungen, and Lohmann & Rauscher are the major suppliers in the anti-biofilm wound dressing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Ebola Drug and Vaccine Market in Canada
Japanese Encephalitis Vaccine Market in Canada
Pet Vaccine Market in Canada
Medical Grade Silicone Market in Canada
Rabies Vaccine Market in Canada
Respiratory Virus Vaccine Market in Canada